3D OPTIMIZED WMN MPRAGE Increased Detection of Focal Spinal Cord Lesion in Multiple Sclerosis (WHINUME)

RecruitingNot a drug-phase studyRelapsing and progressiveNCT05227092

What it found

Still running

No result yet.

What was tested

Treatment tested

  • 3D OPTIMIZED WMN MPRAGE

What it measured

Main measures

  • lesions at the cervical level

    day 1

    MRI lesions

Other measures (9)

  • lesions at the thoracic level

    day 1

    MRI lesions
  • sensitivity of the 3D optimised WMN MPRAGE sequence

    day 1

    MRI lesions
  • positive predictive value of the 3D optimized WMN MPRAGE sequence

    day 1

    MRI lesions
  • Intraclass corelation coefficient

    day 1

    MRI lesions
  • pathogenicity of the lesions

    day 1

    MRI lesions
  • presence of artefacts

    day 1

  • volume of lesion

    day 1

    MRI lesions
  • contrast-to-noise ratio

    day 1

    MRI lesions
  • patient's disability

    day 1

    Disability progression

Who could take part

Relapsing and progressive · 18 and over

Show the full criteria

Inclusion criteria

* Patients older than 18 years old * CIS or RRMS * Medullary symptomatology less than 6 months * With or without an objective lesion on a subsequent MRI scan * Signed the Informed Consent

Exclusion criteria

* Pregnant or potentially pregnant women * Breastfeeding woman * Contraindications to MRI * Other diagnosis (Neuro-myelitis spectrum disease or Progressive Multiple Sclerosis) * Surgical history on the spinal cord or lumbar spine * Patient under legal protection

As registered. Criteria can change, so ask the trial team or your neurologist.

Contact details on the registry

About this trial

In the sponsor's words

The aim of this study is to compare the 3D OPTIMIZED MPRAGE WMN sequence to "conventional sequences" used in spinal cord analysis. The patients will be explored at the cervical level with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 2D sagittal PSIR, 3D T1 MPRAGE sequences, and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE and 3D axial OPTIMIZED WMN MPRAGE. At the thoracic level, with the conventional 2D sagittal T2 FSE, 2D sagittal STIR, 3D T1 MPRAGE sequences and the sequence of interest 3D sagittal OPTIMIZED WMN MPRAGE.

Loading reviews and guidelines…

History

    1. Started

      Aug 2023

    2. Main results due

      May 2026

    3. Finished

      May 2026

    Assembled by software from public sources.